Synthetic enforcement of STING signaling in cancer cells appropriates the immune microenvironment for checkpoint inhibitor therapy.
Science Advances
Vornholz, Larsen L; Isay, Sophie E SE; Kurgyis, Zsuzsanna Z; Strobl, Daniel C DC; Loll, Patricia P; Mosa, Mohammed H MH; Luecken, Malte D MD; Sterr, Michael M; Lickert, Heiko H; Winter, Christof C; Greten, Florian R FR; Farin, Henner F HF; Theis, Fabian J FJ; Ruland, Jürgen J
Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria.
American Journal Of Human Genetics
Pejaver, Vikas V; Byrne, Alicia B AB; Feng, Bing-Jian BJ; Pagel, Kymberleigh A KA; Mooney, Sean D SD; Karchin, Rachel R; O'Donnell-Luria, Anne A; Harrison, Steven M SM; Tavtigian, Sean V SV; Greenblatt, Marc S MS; Biesecker, Leslie G LG; Radivojac, Predrag P; Brenner, Steven E SE; ,
Publication Date: 2022-12-01
Variant appearance in text: ESR1: N153S; rs764125878
A Mutation Outside the Dimerization Domain Causing Atypical STING-Associated Vasculopathy With Onset in Infancy.
Frontiers In Immunology
Saldanha, Rohit G RG; Balka, Katherine R KR; Davidson, Sophia S; Wainstein, Brynn K BK; Wong, Melanie M; Macintosh, Rebecca R; Loo, Christine K C CKC; Weber, Martin A MA; Kamath, Vasanth V; , ; , ; Moghaddas, Fiona F; De Nardo, Dominic D; Gray, Paul Edgar PE; Masters, Seth Lucian SL